Designed synthesis of prussian blue@Cu-doped zinc phosphate nanocomposites for chemo/chemodynamic/photothermal combined cancer therapy-Reference-Cited by-同舟云学术

Designed synthesis of prussian blue@Cu-doped zinc phosphate nanocomposites for chemo/chemodynamic/photothermal combined cancer therapy

Published:2023 Issue:27 Volume:11 Page:6404-6411
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Hu Xiaoxue¹,Song Xiaoning¹^ORCID,Yuan Yuan¹,Yao Xintao¹,Chen Xiangjun²,Li Gang¹^ORCID,Li Shengnan¹^ORCID

Affiliation:

1. School of Chemical Engineering and Technology, Hebei University of Technology, Xiping Road, Tianjin 300401, P. R. China

2. School of Pharmacy, Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, 346 Guanhai Road, Yantai 264003, P. R. China

Abstract

PB@Cu2+/ZnP NPs with drug-loading property, photothermal effect, Fenton-like catalytic performance and high biosafety have been fabricated for synergistic chemo/chemodynamic/photothermal therapy.

Funder

Natural Science Foundation of Hebei Province

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2023/TB/D3TB00342F

Reference41 articles.

1. Cancer Statistics, 2021

2. Fabrication of injectable hydrogels from an anticancer peptide for local therapeutic delivery and synergistic photothermal–chemotherapy

3. Reduction-Responsive Chemo-Capsule-Based Prodrug Nanogel for Synergistic Treatment of Tumor Chemotherapy

4. A Self-Driven Bioreactor Based on Bacterium–Metal–Organic Framework Biohybrids for Boosting Chemotherapy via Cyclic Lactate Catabolism

5. Recent advances in phase change material based nanoplatforms for cancer therapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in the Application of the Fenton Reaction in the Cancer Microenvironment;Pharmaceutics;2023-09-18